Longevity Health Holdings, Inc. (XAGE): Nasdaq/NYSE listing notice — Carmell receives Nasdaq delisting notice for failing MVLS minimum; plans appeal

Longevity Health Holdings, Inc.

Failed to regain $35M MVLS compliance by Feb 26, 2025 deadline; notice received March 4.
Must appeal by March 11, 2025 or trading suspended on March 13; Form 25-NSE to follow.
Company intends to appeal but cautions no guarantee of success for continued listing.
Redeemable warrants (CTCXW) also subject to delisting along with common stock (CTCX).

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Longevity Health Holdings, Inc. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: market value
Rules: 5550(b)(2), 5810(c)(3)(C)

Exact text from the filing

March 4, 2025, the Company received written notice from the Department notifying the Company that it had failed to regain compliance with the MVLS Requirement by the Compliance Date. As such, unless the Company requests an appeal of Nasdaq’s determination to delist the Company’s securities from the Nasdaq Capital Market by March 11, 2025, trading of the Company’s common stock will be suspended at the opening of business on March 13, 2025, and a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing and registra

View on SEC.gov

Browse all listing & compliance notices →

Longevity Health Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-033793

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.